Langzeitbetreuung lebertransplantierter Kinder und Jugendlicher

Zusammenfassung

Jährlich werden in Deutschland mehr als 100 Kinder und Jugendliche erfolgreich lebertransplantiert. Die Nachsorge dieser Kinder erfolgt meist in Partnerschaft zwischen den heimatnah niedergelassenen Kinder- und Jugendärzten, Kinderkliniken vor Ort und den Transplantationszentren. Neben der allgemeinen kinderärztlichen Versorgung ergeben sich für die niedergelassenen Fachärzte Besonderheiten unter anderem durch häufige Blutentnahmen zur Kontrolle von Leberfunktion, Immunsuppression und virologischem Monitoring. Im Umgang mit Infektionen bei den transplantierten Kindern müssen Besonderheiten bei der Auswahl von Antibiotika und die Möglichkeit einer Cholangitis als Differenzialdiagnose bedacht werden. Hinzu kommen Besonderheiten in der Beratung der Eltern und Patienten bezüglich Impfungen und Infektionsprävention. In der jugendmedizinischen Betreuung gewinnen besondere Aspekte bei der Beratung zu Körperbild, Sexualität, Berufswahl und Umgang mit Noxen an Bedeutung.

Summary

Approximately 100 patients annually undergo liver transplantation in Germany. Post-transplant care is usually organized as “shared care” between the transplantation centres and local primary care paediatricians. In addition to general paediatric care and follow-up, liver transplantation often requires frequent and regular clinical and laboratory monitoring. Intercurrent viral and bacterial infections might need a different approach compared to otherwise healthy children. The choice of antibiotics needs to consider drug interactions with immunosuppressive drugs. Rare and specific complications like cholangitis or viral infections may be observed. Counselling with regards to vaccination and prevention of infection needs to take into account the drug-induced immunosuppression. Care for the growing adolescent should incorporate topics such as body image, sexuality, career choice and professional development and substance (ab)use, some of which can be significantly influenced by the transplant experience and health care necessities.

Schlüsselwörter

Lebertransplantation - Nachsorge - Impfungen - Immunsuppression

Keywords

Liver transplantation - post-transplant care - vaccination - immunosuppression

• Literatur

• 1 Farmer DG, Venick RS, McDiarmid SV. et al. Predictors of outcomes after pediatric liver transplantation: an analysis of more than 800 cases performed at a single institution. J Am Coll Surg 2007; 204: 904-914.
• 2 Oh SH, Kim KM, Kim DY. et al. Clinical experience of more than 200 cases of pediatric liver transplantation at a single center: improved patient survival. Transplant Proc 2012; 44: 484-486.
• 3 Pfister ED, Baumann U. Lebertransplantation. In: Reinhardt D, Nicolai T, Zimmer K-P. (eds). Therapie der Krankheiten im Kindes- und Jugendalter. 9 ed.. Heidelberg: Springer; 2014: 1507-1509.
• 4 Corey RL, Rakela J. Complementary and alternative medicine: risks and special considerations in pretransplant and posttransplant patients. Nutr Clin Pract 2014; 29: 322-331.
• 5 Chitturi S, Farrell GC. Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol 2000; 15: 1093-1099.
• 6 Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med 2013; 13: 7-12.
• 7 Gotoh K, Ito Y, Ohta R. et al. Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads. J Infect Dis 2010; 202: 461-469.
• 8 D’Antiga L, Del RM, Mengoli C. et al. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD. Liver Transpl 2007; 13: 343-348.
• 9 Orentas RJ, Schauer Jr. DW, Ellis FW. et al. Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients. Pediatr Transplant 2003; 7: 305-314.
• 10 Jang JY, Kim KM, Lee YJ. et al. Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation. Transplant Proc 2008; 40: 2546-2548.
• 11 Hanngren K, Falksveden L, Grandien M, Lidin-Janson G. Zoster immunoglobulin in varicella prophylaxis. A study among high-risk patients. Scand J Infect Dis 1983; 15: 327-334.
• 12 Suga S, Yoshikawa T, Ozaki T, Asano Y. Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Arch Dis Child 1993; 69: 639-642.
• 13 Pergam SA, Limaye AP. Varicella zoster virus (VZV) in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl. 04) S108-S115.
• 14 Posfay-Barbe KM, Pittet LF, Sottas C. et al. Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic. Am Transplant 2012; 12: 2974-2985.
• 15 Zamora I, Simon JM, Da Silva ME, Piqueras AI. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 1994; 8: 190-192.
• 16 Khan S, Erlichman J, Rand EB. Live virus immunization after orthotopic liver transplantation. Pediatr Transplant 2006; 10: 78-82.
• 17 Prelog M, Schonlaub J, Jeller V. et al. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients. Vaccine 2013; 31: 2420-2426.
• 18 Aberg F, Makisalo H, Hockerstedt K. et al. Infectious complications more than 1 year after liver transplantation: a 3-decade nationwide experience. Am J Transplant 2011; 11: 287-295.
• 19 Sieders E, Peeters PM, Tenvergert EM. et al. Graft loss after pediatric liver transplantation. Ann Surg 2002; 235: 125-132.
• 20 Millonig G, Buratti T, Graziadei IW. et al. Bactobilia after liver transplantation: frequency and antibiotic susceptibility. Liver Transpl 2006; 12: 747-753.
• 21 Danerseau AM, Robinson JL. Efficacy and safety of measles, mumps, rubella and varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs. World J Pediatr 2008; 4: 254-258.
• 22 Kawano Y, Suzuki M, Kawada J. et al. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Vaccine 2015; 33: 1440-1445.
• 23 Shinjoh M, Hoshino K, Takahashi T, Nakayama T. Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine 2015; 33: 701-707.
• 24 Chin SE, Shepherd RW, Thomas BJ. et al. The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation. Am J Clin Nutr 1992; 56: 164-168.
• 25 Perito ER, Glidden D, Roberts JP, Rosenthal P. Overweight and obesity in pediatric liver transplant recipients: prevalence and predictors before and after transplant, United Network for Organ Sharing Data, 1987–2010. Pediatr Transplant 2012; 16: 41-49.
• 26 Kaufman M, Shemesh E, Benton T. The adolescent transplant recipient. Pediatr Clin N Am 2010; 57: 575-592.
• 27 Wright J, Elwell L, McDonagh JE. et al. ’It’s hard but you’ve just gotta get on with it’ – The experiences of growing-up with a liver transplant. Psychol Health 2015; 1-17.
• 28 Jabiry-Zieniewicz Z, Bobrowska K, Kaminski P. et al. Low-dose hormonal contraception after liver transplantation. Transplant Proc 2007; 39: 1530-1532.
• 29 Westbrook RH, Yeoman AD, Agarwal K. et al. Outcomes of Pregnancy following liver transplantation: The King’s College Hospital experience. Liver Transplantation 2015; 21: 1153-1159.
• 30 Songin T, Pietrzak B, Brawura-Biskupski-Samaha R. et al. Pregnancy after Kidney and Liver Transplantation: Its Outcome and Effect on the Graft, Mother and Neonate. Ann Transplant 2014; 19: 660-666.